Search results
Pfizer Unusual Options Activity - Pfizer (NYSE:PFE)
Benzinga· 6 days agoLoading... Loading... Whales with a lot of money to spend have taken a noticeably bearish stance on Pfizer . Looking at options history for Pfizer PFE we ...
1 High-Yield ETF Could Turn $400 Per Month Into $50,000 In Annual Dividend Income
Motley Fool via Yahoo Finance· 16 hours agoDividend Equity ETF are: Texas Instruments (2.6% dividend yield) Amgen (2.9%) Lockheed Martin (2.7%)...
Pfizer (PFE) Recently Broke Out Above the 200-Day Moving Average
Zacks via Yahoo Finance· 3 days agoFrom a technical perspective, Pfizer (PFE) is looking like an interesting pick, as it just reached a...
Pfizer targets $1.5 billion in savings by 2027 as it streamlines operations
WSAU Wausau· 4 days ago(Reuters) -U.S. drugmaker Pfizer said on Wednesday it had launched a multi-year program to reduce...
Pfizer Inc.’s latest rating changes from various analysts – Knox Daily
Knox Daily· 7 days agoPfizer Inc.’s recently made public that its Director Gottlieb Scott acquired Company’s shares for reported $79401.0 on Dec 15 ’23. In the deal valued at $26.47 per share,3,000 ...
Sen. Wyden questions Pfizer over tax rate as part of ongoing investigation
Endpoints News· 5 days agoSenate Finance Chair Ron Wyden (D-OR) is pressing Pfizer over its tax practices as part of his investigation into how large pharma companies use subsidiaries in other countries ...
Pfizer to Cut Costs in Multi-Year Effort
The Wall Street Journal· 4 days agoThe company said it estimates savings of $1.5 billion in the plan’s first phase by the end of 2027.
HILL TAX BRIEF: Wyden Blasts Pfizer on International Tax Shifts
Bloomberg Law· 5 days agoSenate Finance Committee Chair Ron Wyden (D-Ore.) is expanding his investigation into profit-shifting practices of pharmaceutical companies with a new letter to drug powerhouse Pfizer.
Got $500? 3 Pharma Stocks to Buy and Hold Forever | The Motley Fool
The Motley Fool· 11 hours agoWith that in mind, let's examine three leading pharma stocks that are ripe for buying today and...
Pfizer (PFE) Recently Broke Out Above the 200-Day Moving Average
Zacks· 4 days agoFree Report) is looking like an interesting pick, as it just reached a key level of support. PFE recently overtook the 200-day moving average, and this suggests a long-term bullish trend. The ...